Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen
- PMID: 8176208
Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen
Abstract
The natural Ag influenza virus A was used to test the requirements for the HLA-DR1-restricted presentation of the epitopes 18-29 in the matrix protein and 307-318 in the hemagglutinin protein. CD4+ cytotoxic T cell clones of similar efficiency were used to detect presentation of these two epitopes. Presentation of the matrix epitope by APC pulsed with either inactivated virus particles or purified soluble protein followed the classical pathway in that 1) it required invariant chain expression, 2) it was blocked by inhibition of protein synthesis, and 3) it was dependent on a function(s) encoded in the MHC class II region. These characteristics suggest that peptides corresponding to the matrix epitope can only load onto newly synthesized class II molecules that were targeted to a processing compartment by the invariant chain. In contrast, presentation of the hemagglutinin epitope processed from virus particles followed a different pathway. First, presentation of hemagglutinin was independent of invariant chain expression. Second, a human B lymphoblastoid cell line in which protein synthesis was inhibited for 9 h was still able to present hemagglutinin even at very low doses of Ag. Third, a DR1-transfected mutant B cell line missing the MHC class II region was able to present hemagglutinin. Thus, mature class II alpha beta molecules can acquire immunogenic peptides derived from intact natural Ags for presentation to CD4+ T cells. This pathway may be useful for the binding of peptides derived from Ags that are rapidly degraded upon uptake into APC.
Similar articles
-
Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.J Immunol. 1993 Dec 15;151(12):6751-6. J Immunol. 1993. PMID: 8258689
-
The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.Eur J Immunol. 1994 Jul;24(7):1632-9. doi: 10.1002/eji.1830240727. Eur J Immunol. 1994. PMID: 8026524
-
Class II MHC molecules can use the endogenous pathway of antigen presentation.Nature. 1990 Jan 4;343(6253):74-6. doi: 10.1038/343074a0. Nature. 1990. PMID: 1967486
-
The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.Crit Rev Immunol. 1996;16(4):359-79. Crit Rev Immunol. 1996. PMID: 8954255 Review.
-
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.Immunol Rev. 1987 Aug;98:95-114. doi: 10.1111/j.1600-065x.1987.tb00521.x. Immunol Rev. 1987. PMID: 2443444 Review.
Cited by
-
Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome.J Cell Biol. 1998 Jun 1;141(5):1121-34. doi: 10.1083/jcb.141.5.1121. J Cell Biol. 1998. PMID: 9606205 Free PMC article.
-
Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.Infect Immun. 2010 Dec;78(12):5138-50. doi: 10.1128/IAI.00155-10. Epub 2010 Sep 27. Infect Immun. 2010. PMID: 20876292 Free PMC article.
-
Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.J Exp Med. 2000 May 1;191(9):1513-24. doi: 10.1084/jem.191.9.1513. J Exp Med. 2000. PMID: 10790426 Free PMC article.
-
Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.Immunology. 1996 Mar;87(3):481-6. doi: 10.1046/j.1365-2567.1996.483556.x. Immunology. 1996. PMID: 8778037 Free PMC article.
-
Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.Immunology. 2001 Jul;103(3):319-31. doi: 10.1046/j.1365-2567.2001.01238.x. Immunology. 2001. PMID: 11454061 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
